Trial Profile

A clinical trial of 177Lu-PSMA-I for prostate cancer

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 06 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 Oct 2025 New trial record
08 Jul 2025 Accoridng to a PeptiDream media release, company today announced that PDRadiopharma Inc, has submitted investigational new drug (IND) applications to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the initiation of clinical trials of 177Lu-PSMA-I&T.
08 Jul 2025 According to a media release from PeptiDream, the trial aims to utilize data from Curium's ongoing global studies to support and accelerate regulatory approval in Japan.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com